Pharma BD Deal Intelligence

Quintiles Transnational Holdings Inc. / IMS Health Holdings, Inc.

2016 · Acquisition/Merger · $17.6B · Complete

Quintiles and IMS Health agreed to an all-stock merger of equals to create a leading global integrated information and technology-enabled healthcare services provider. Combined enterprise value ~$17.6B (combined market cap ~$23B); IMS shareholders received 51.4% of combined company, Quintiles shareholders 48.6%. Closed October 3, 2016 as Quintiles IMS; rebranded IQVIA in November 2017.

Did it work? Outcome assessment

Assessment window: 5yr post-close.

Key facts

• Announced May 03, 2016
• Closed Oct 03, 2016
• Deal value $17.6B
• Deal type Acquisition/Merger
• Therapeutic area N/A (services/data)
• Indications N/A (services/data)
• Key assets Combined CRO + healthcare data/technology platform (later branded QuintilesIMS, then IQVIA)
• Mechanism Real-world data, clinical trial services, commercial analytics

← Browse all deals  ·  How we score deals